⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Bruluagsa S.A. de C.V. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Bruluagsa S.A. de C.V.
↗Atlacomulco, Mexico
Bruluagsa S.A. de C.V. is a Mexican pharmaceutical company and part of the Grupo Bruluart conglomerate. The company specializes in the manufacturing and distribution of generic medications, focusing on providing high-quality, safe, and effective pharmaceutical solutions to the Mexican population.
Operating primarily out of Atlacomulco, State of Mexico, the company maintains significant manufacturing facilities and is a frequent supplier in public health tenders, including contracts for the Mexican Social Security Institute (IMSS) and other state health entities. Their product portfolio includes a wide range of therapeutic categories such as analgesics, antibiotics, and anti-inflammatories.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:2000
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Grupo Bruluart
Key Partnerships:Instituto Mexicano del Seguro Social (IMSS) - Supplier, Instituto de Salud del Estado de México (ISEM) - Supplier
COMPETITION
Position:Niche Player
Competitors:Laboratorios PiSA, Grimann, Maver
LEADERSHIP
Key Executives:
Francisco Ortega Piedra - Representative/Contact
LINKS
Website:bruluagsa.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bruluagsa S.A. de C.V.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.